Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Van Etten

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Cancer Cell|July 12, 2011
BCL6: a novel target for therapy of Ph+ B cell acute lymphoblastic leukemiaRichard A Van Etten
Oncogene|December 12, 2002
Studying the pathogenesis of BCR-ABL+ leukemia in miceRichard A Van Etten
Current Biology : CB|August 9, 2003
c-Abl regulation: a tail of two lipidsRichard A Van Etten
Leukemia Research|March 24, 2004
Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib eraRichard A Van Etten
The Journal of Experimental Medicine|March 14, 2007
Oncogenic signaling: new insights and controversies from chronic myeloid leukemiaRichard A Van Etten
Cytometry. Part B, Clinical Cytometry|January 9, 2013
New insights into the normal and leukemic stem cell niche: a timely reviewRichard A Van Etten
Current Hematologic Malignancy Reports|January 12, 2013
Signal transduction in the chronic leukemias: implications for targeted therapiesWesam Ahmed, Richard A Van Etten
Hematology. American Society of Hematology. Education Program|December 10, 2013
Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyondWesam Ahmed, Richard A Van Etten
Cancer Cell|April 20, 2005
JAKing up hematopoietic proliferationKevin Shannon, Richard A Van Etten
Trends in Molecular Medicine|November 6, 2007
Right on target: eradicating leukemic stem cellsDaniela S Krause, Richard A Van Etten
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Cancer Cell|July 12, 2011
BCL6: a novel target for therapy of Ph+ B cell acute lymphoblastic leukemiaRichard A Van Etten
Oncogene|December 12, 2002
Studying the pathogenesis of BCR-ABL+ leukemia in miceRichard A Van Etten
Current Biology : CB|August 9, 2003
c-Abl regulation: a tail of two lipidsRichard A Van Etten
Leukemia Research|March 24, 2004
Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib eraRichard A Van Etten
The Journal of Experimental Medicine|March 14, 2007
Oncogenic signaling: new insights and controversies from chronic myeloid leukemiaRichard A Van Etten
Cytometry. Part B, Clinical Cytometry|January 9, 2013
New insights into the normal and leukemic stem cell niche: a timely reviewRichard A Van Etten
Current Hematologic Malignancy Reports|January 12, 2013
Signal transduction in the chronic leukemias: implications for targeted therapiesWesam Ahmed, Richard A Van Etten
Hematology. American Society of Hematology. Education Program|December 10, 2013
Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyondWesam Ahmed, Richard A Van Etten
Cancer Cell|April 20, 2005
JAKing up hematopoietic proliferationKevin Shannon, Richard A Van Etten
Trends in Molecular Medicine|November 6, 2007
Right on target: eradicating leukemic stem cellsDaniela S Krause, Richard A Van Etten
Pageof 8